175 related articles for article (PubMed ID: 38256912)
1. Cytocidal Effect of Irradiation on Gastric Cancer Cells Infected with a Recombinant Mammalian Orthoreovirus Expressing a Membrane-Targeted KillerRed.
Shirasaka Y; Yamada K; Etoh T; Noguchi K; Hasegawa T; Ogawa K; Kobayashi T; Nishizono A; Inomata M
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256912
[TBL] [Abstract][Full Text] [Related]
2. Generation of Genetically RGD σ1-Modified Oncolytic Reovirus That Enhances JAM-A-Independent Infection of Tumor Cells.
Kawagishi T; Kanai Y; Nouda R; Fukui I; Nurdin JA; Matsuura Y; Kobayashi T
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907973
[TBL] [Abstract][Full Text] [Related]
3. Development of an oncolytic mammalian orthoreovirus expressing the near-infrared fluorescent protein iRFP720.
Ogawa K; Yamada K; Etoh T; Kitagawa M; Shirasaka Y; Noguchi K; Kobayashi T; Nishizono A; Inomata M
J Virol Methods; 2022 Oct; 308():114574. PubMed ID: 35798198
[TBL] [Abstract][Full Text] [Related]
4.
Kanai Y; Kawagishi T; Matsuura Y; Kobayashi T
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068423
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
Mohamed A; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
[TBL] [Abstract][Full Text] [Related]
6. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
[TBL] [Abstract][Full Text] [Related]
7. Creation and characterization of a recombinant mammalian orthoreovirus expressing σ1 fusion proteins encoding human epidermal growth factor receptor 2 peptides.
Jandick NA; Miller CL
Virology; 2023 Oct; 587():109871. PubMed ID: 37634292
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a Replicating Mammalian Orthoreovirus with Tetracysteine-Tagged μNS for Live-Cell Visualization of Viral Factories.
Bussiere LD; Choudhury P; Bellaire B; Miller CL
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878073
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model.
Kawaguchi K; Etoh T; Suzuki K; Mitui MT; Nishizono A; Shiraishi N; Kitano S
Int J Oncol; 2010 Dec; 37(6):1433-8. PubMed ID: 21042711
[TBL] [Abstract][Full Text] [Related]
10. Features of the mammalian orthoreovirus 3 Dearing l1 single-stranded RNA that direct packaging and serotype restriction.
Roner MR; Steele BG
J Gen Virol; 2007 Dec; 88(Pt 12):3401-3412. PubMed ID: 18024910
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic Reoviruses: Can These Emerging Zoonotic Reoviruses Be Tamed and Utilized?
Siew ZY; Loh A; Segeran S; Leong PP; Voon K
DNA Cell Biol; 2023 Jun; 42(6):289-304. PubMed ID: 37015068
[TBL] [Abstract][Full Text] [Related]
12. Reverse genetics for mammalian reovirus.
Boehme KW; Ikizler M; Kobayashi T; Dermody TS
Methods; 2011 Oct; 55(2):109-13. PubMed ID: 21798351
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of a novel reassortment Mammalian orthoreovirus type 2 isolated from a Florida white-tailed deer fawn.
Ahasan MS; Subramaniam K; Sayler KA; Loeb JC; Popov VL; Lednicky JA; Wisely SM; Campos Krauer JM; Waltzek TB
Virus Res; 2019 Sep; 270():197642. PubMed ID: 31228510
[TBL] [Abstract][Full Text] [Related]
14. Pteropine Orthoreovirus, PRV7S (Sikamat Virus) Demonstrates Oncolysis in Nasopharyngeal Carcinoma Cell Lines.
Loh A; Shaibie NA; Chan PQ; Leong PP; Segeran S; Tan BK; Wong ST; Koh RY; Chye SM; Voon K
Front Biosci (Landmark Ed); 2022 Apr; 27(4):138. PubMed ID: 35468697
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene.
Kemp V; Dautzenberg IJC; Cramer SJ; Hoeben RC; van den Wollenberg DJM
Gene Ther; 2018 Aug; 25(5):331-344. PubMed ID: 30013187
[TBL] [Abstract][Full Text] [Related]
16. Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.
Takehara K; Tazawa H; Okada N; Hashimoto Y; Kikuchi S; Kuroda S; Kishimoto H; Shirakawa Y; Narii N; Mizuguchi H; Urata Y; Kagawa S; Fujiwara T
Mol Cancer Ther; 2016 Jan; 15(1):199-208. PubMed ID: 26625896
[TBL] [Abstract][Full Text] [Related]
17. Modification of mammalian reoviruses for use as oncolytic agents.
Van Den Wollenberg DJ; Van Den Hengel SK; Dautzenberg IJ; Kranenburg O; Hoeben RC
Expert Opin Biol Ther; 2009 Dec; 9(12):1509-20. PubMed ID: 19916732
[TBL] [Abstract][Full Text] [Related]
18. Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines.
van den Wollenberg DJM; Kemp V; Rabelink MJWE; Hoeben RC
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768641
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin 1 Receptor - A Unique
Jiang HN; Li Y; Jiang WY; Cui ZJ
Front Physiol; 2018; 9():497. PubMed ID: 29867546
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer.
Kyula JN; Roulstone V; Karapanagiotou EM; Melcher AA; Harrington KJ
Expert Opin Biol Ther; 2012 Dec; 12(12):1669-78. PubMed ID: 23140488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
